公司新闻

bbin新体育2018年学术系列讲座(一)

  2018年4月18日,bbin新体育2018年学术系列讲座在创想园举办。我们非常荣幸地邀请了Alex Matter博士做了题目为‘Personalized anticancer drug discovery & development in Asia’ 的学术讲座。


Dr Alex Matter is CEO of the Experimental Therapeutics Centre since April 2009 and since January 2012 CEO of the newly created D3 platform, A*STAR, Singapore. Previously, he had spent five and a half years as Director of the Novartis Institute for Tropical Diseases (NITD), from October 2003 to February 2009. Prior to this role, Dr. Matter was Global Head of Oncology Research for Novartis Pharmaceuticals Corporation. Dr. Matter played an important role in the success of several anticancer drugs, including Gleevec/Glivec® .


2.jpg

公司总经理邹斌博士对Alex博士的到来表示欢迎并进行了介绍。


3.jpg

4.jpg

Alex博士满怀激情地分享了药物研究开发的故事和体会,现场听众十分投入。


5.jpg

6.jpg

会后,Alex博士对听众提出的问题进行一一答复。


上一个:No more! 下一个:“青”尽全力,“煜”药于新>

新闻分类

联系我们

上海bbin新体育科技有限公司

联系人:林女士

电话:021-61160506-6121

zhaopin@blueraybiopharma.com

地址:上海浦东李冰路576号3号楼1楼